• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者采用膀胱过度活动症问卷评估膀胱症状。

Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.

机构信息

Department of Neurological Sciences, University of Rome Sapienza, Rome, Italy.

出版信息

Mov Disord. 2010 Jul 15;25(9):1203-9. doi: 10.1002/mds.23093.

DOI:10.1002/mds.23093
PMID:20310046
Abstract

In Parkinson's disease (PD) the urinary dysfunction manifests primarily with symptoms of overactive bladder (OAB). The OAB questionnaire (OAB-q) is a measure designed to assess the impact of OAB symptoms on health-related quality of life. In this study, we quantified the urinary symptoms in a large cohort of PD patients by using the OAB-q short form. Possible correlations between the OAB-q and clinical features were tested. Three hundred and two PD patients were enrolled in the study. Correlations between the OAB-q and sex, age, Unified Parkinson's Disease Rating Scale part III (UPDRS-III), Hoehn-Yahr (H-Y) staging, disease duration, and treatment were analyzed. Data were compared with a large cohort of 303 age-matched healthy subjects. The OAB-q yielded significantly higher scores in PD patients than in healthy subjects. In the group of PD patients, all the variables tested were similar between men and women. Pearson's coefficient showed a significant correlation between mean age, disease duration, mean OAB-q scores, UPDRS-III scores, and H-Y staging. A multiple linear regression analysis showed that OAB-q values were significantly influenced by age and UPDRS-III. No statistical correlations were found between OAB-q scores and drug therapy or the equivalent levodopa dose, whilst the items relating to the nocturia symptoms were significantly associated with the equivalent levodopa dose. Our findings suggest that bladder dysfunction assessed by OAB-q mainly correlates with UPDRS-III scores for severity of motor impairment, possibly reflecting the known role of the decline in nigrostriatal dopaminergic function in bladder dysfunction associated with PD and patients' age. Our study also suggests that the OAB-q is a simple, easily administered test that can objectively evaluate bladder function in patients with PD.

摘要

在帕金森病(PD)中,尿功能障碍主要表现为膀胱过度活动症(OAB)的症状。OAB 问卷(OAB-q)是一种旨在评估 OAB 症状对健康相关生活质量影响的测量方法。在这项研究中,我们使用 OAB-q 短表来量化大量 PD 患者的尿症状。测试了 OAB-q 与临床特征之间的可能相关性。研究共纳入 302 名 PD 患者。分析了 OAB-q 与性别、年龄、统一帕金森病评定量表第三部分(UPDRS-III)、Hoehn-Yahr(H-Y)分期、疾病持续时间和治疗之间的相关性。将数据与 303 名年龄匹配的健康受试者的大队列进行比较。与健康受试者相比,PD 患者的 OAB-q 评分显著更高。在 PD 患者组中,所有测试变量在男性和女性之间均相似。Pearson 系数显示平均年龄、疾病持续时间、平均 OAB-q 评分、UPDRS-III 评分和 H-Y 分期之间存在显著相关性。多元线性回归分析显示,OAB-q 值受年龄和 UPDRS-III 的显著影响。OAB-q 评分与药物治疗或等效左旋多巴剂量之间未发现统计学相关性,而与夜尿症症状相关的项目与等效左旋多巴剂量显著相关。我们的研究结果表明,OAB-q 评估的膀胱功能主要与 UPDRS-III 评估的运动障碍严重程度相关,这可能反映了中脑黑质多巴胺能功能下降在与 PD 相关的膀胱功能障碍和患者年龄中的已知作用。我们的研究还表明,OAB-q 是一种简单、易于管理的测试方法,可以客观地评估 PD 患者的膀胱功能。

相似文献

1
Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.帕金森病患者采用膀胱过度活动症问卷评估膀胱症状。
Mov Disord. 2010 Jul 15;25(9):1203-9. doi: 10.1002/mds.23093.
2
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).索利那新治疗膀胱过度活动症后的症状困扰及健康相关生活质量结局:卫喜康开放标签试验(VOLT)
Clin Ther. 2006 Nov;28(11):1935-46. doi: 10.1016/j.clinthera.2006.11.010.
3
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.帕金森病患者在抗毒蕈碱治疗期间出现神经源性逼尿肌过度活动,膀胱过度活动症问卷(OAB-q)与尿动力学数据之间的相关性
Clin Neuropharmacol. 2006 Jul-Aug;29(4):220-9. doi: 10.1097/01.WNF.0000228177.75711.0f.
4
Effects of dopaminergic treatment on bladder function in Parkinson's disease.多巴胺能治疗对帕金森病膀胱功能的影响。
Neurourol Urodyn. 2004;23(7):689-96. doi: 10.1002/nau.20054.
5
Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).四种膀胱过度活动症患者问卷的重测信度:膀胱过度活动症问卷(OAB-q)、患者膀胱状况感知问卷(PPBC)、尿急问卷(UQ)以及原发性膀胱过度活动症症状问卷(POSQ)。
Neurourol Urodyn. 2005;24(3):215-25. doi: 10.1002/nau.20110.
6
Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.35例伴有快速眼动睡眠行为障碍的帕金森病患者的临床特征
Clin Neurol Neurosurg. 2005 Jun;107(4):306-9. doi: 10.1016/j.clineuro.2004.09.021. Epub 2004 Nov 11.
7
Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.用托特罗定治疗的膀胱过度活动症患者症状改善与膀胱状况、症状困扰及健康相关生活质量的患者评估之间的关系。
Int J Clin Pract. 2008 Jun;62(6):925-31. doi: 10.1111/j.1742-1241.2008.01778.x.
8
Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters.帕金森病患者的排尿功能障碍:神经功能损害和临床参数的影响
Neurourol Urodyn. 2009;28(6):510-5. doi: 10.1002/nau.20681.
9
The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.膀胱过度活动症、尿失禁及其他下尿路症状对男性和女性生活质量、工作效率、性功能及情绪健康的影响:EPIC研究结果
BJU Int. 2008 Jun;101(11):1388-95. doi: 10.1111/j.1464-410X.2008.07601.x.
10
Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).膀胱过度活动症治疗满意度问卷(OAB-SAT-q)的心理测量学验证
Neurourol Urodyn. 2009;28(5):416-22. doi: 10.1002/nau.20672.

引用本文的文献

1
The Impact of Polypharmacy on Management of Lower Urinary Tract Symptoms in Parkinson's Disease.多药治疗对帕金森病下尿路症状管理的影响。
Drugs Aging. 2023 Oct;40(10):909-917. doi: 10.1007/s40266-023-01060-2. Epub 2023 Aug 31.
2
Nocturia and Sleep in Parkinson's Disease.帕金森病中的夜尿症与睡眠
J Pers Med. 2023 Jun 27;13(7):1053. doi: 10.3390/jpm13071053.
3
A Novel Trial of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO).米拉贝隆与行为矫正(包括盆底肌锻炼)治疗帕金森病膀胱过度活动症的一项新试验(MAESTRO)。
Cureus. 2022 Nov 23;14(11):e31818. doi: 10.7759/cureus.31818. eCollection 2022 Nov.
4
Relationship between Lower Urinary Tract Dysfunction and Clinical Features in Chinese Parkinson's Disease Patients.中国帕金森病患者下尿路功能障碍与临床特征的关系
Parkinsons Dis. 2019 Mar 5;2019:6820937. doi: 10.1155/2019/6820937. eCollection 2019.
5
Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.帕金森病泌尿症状临床评定量表:批判与建议
Mov Disord Clin Pract. 2018 Oct 25;5(5):479-491. doi: 10.1002/mdc3.12636. eCollection 2018 Sep-Oct.
6
A Review of Scales to Evaluate Sleep Disturbances in Movement Disorders.运动障碍睡眠障碍评估量表综述
Front Neurol. 2018 May 29;9:369. doi: 10.3389/fneur.2018.00369. eCollection 2018.
7
A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.2005 年至 2015 年帕金森病睡眠和觉醒障碍文献的系统回顾。
Sleep Med Rev. 2017 Oct;35:33-50. doi: 10.1016/j.smrv.2016.08.001. Epub 2016 Aug 31.
8
Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction.多发性硬化症合并下尿路功能障碍患者神经源性膀胱症状评分与尿动力学检查之间的关联
Int Neurourol J. 2015 Dec;19(4):272-7. doi: 10.5213/inj.2015.19.4.272. Epub 2015 Dec 28.
9
Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation.糖尿病患者的膀胱过度活动症:一项基于问卷的观察性调查。
World J Urol. 2014 Aug;32(4):1021-5. doi: 10.1007/s00345-013-1175-3. Epub 2013 Oct 8.
10
Overactive bladder in elderly men: epidemiology, evaluation, clinical effects, and management.老年男性膀胱过度活动症:流行病学、评估、临床影响和管理。
Curr Urol Rep. 2013 Oct;14(5):418-25. doi: 10.1007/s11934-013-0367-0.